Silvia Taylor | Associate Director, Investor Relations and Public Relations |
Stan Erck | President and CEO |
John Trizzino | Chief Business Officer and CFO |
Gregory Glenn | President of Research and Development |
Filip Dubovsky | Chief Medical Officer |
Eric Joseph | JPMorgan |
Charles Duncan | Cantor Fitzgerald |
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Second Quarter 2020 Financial Operating Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Silvia Taylor. Ma’am, you may begin.
Thank you, Operator. Good afternoon and thank you to everyone who has joined today's call to discuss our second quarter 2020 operational highlights and financial results.